| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
| PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | BMJ, The | 2021 | 666 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Systematic Reviews | 2021 | 513 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 461 |
| Age-specific mortality and immunity patterns of SARS-CoV-2 | Nature | 2021 | 399 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | PLoS Medicine | 2021 | 286 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Journal of Clinical Epidemiology | 2021 | 201 |
| Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts | International Journal of Infectious Diseases | 2021 | 132 |
| The Lancet Global Health Commission on Global Eye Health: vision beyond 2020 | The Lancet Global Health | 2021 | 131 |
| Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers | Journal of Clinical Microbiology | 2021 | 101 |
| Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited | Cancer Discovery | 2021 | 95 |
| Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis | The Lancet Global Health | 2021 | 93 |
| Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland | Lancet Infectious Diseases, The | 2021 | 92 |
| Child Growth and Adolescent Pregnancy: A Longitudinal Sibling Comparison in Peru | Current Developments in Nutrition | 2021 | 78 |
| Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data | Lancet Infectious Diseases, The | 2021 | 75 |
| Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018 | New England Journal of Medicine | 2021 | 71 |
| Improving reporting standards for polygenic scores in risk prediction studies | Nature | 2021 | 70 |
| Household COVID-19 risk and in-person schooling | Science | 2021 | 69 |
| Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility | JAMA - Journal of the American Medical Association | 2021 | 60 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis | Clinical Infectious Diseases | 2021 | 60 |
| Infectious disease in an era of global change | Nature Reviews Microbiology | 2021 | 52 |
| Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study | Lancet, The | 2021 | 51 |
| The trans-ancestral genomic architecture of glycemic traits | Nature Genetics | 2021 | 44 |
| Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case-control study in six countries | BMJ Nutrition, Prevention and Health | 2021 | 42 |
| Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis | Clinical Infectious Diseases | 2021 | 41 |
